| Patient | Muhammad Ali |
|---|---|
| Date of birth | 1942-01-17 |
| Identifiers | MRN HR-BX001-SYN-TD; SSN (made up) 000-01-7724 |
| Document date | 1996-02-10 |
| Author | Celeste Moreau, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing primary care for Parkinson's disease: motor, non-motor, fall-risk, and orthostatic assessment. [S]
Hemoglobin: 14.6 g/dL; Sodium: 140 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 1.02 mg/dL; eGFR: 87 mL/min/1.73 m²; Glucose: 92 mg/dL; Calcium: 9.5 mg/dL; Vitamin B12: 512 pg/mL; TSH: 1.8 mIU/L; MoCA: 27; PHQ-9: 3. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1996-02-10 | Body height | 191 | cm | S |
| 1996-02-10 | Body weight | 102 | kg | S |
| 1996-02-10 | Body mass index (BMI) [Ratio] | 28 | kg/m2 | S |
| 1996-02-10 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1996-02-10 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1996-02-10 | Heart rate | 72 | /min | S |
| 1996-02-10 | Respiratory rate | 14 | /min | S |
| 1996-02-10 | Body temperature | 36.7 | Cel | S |
| 1996-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1996-02-10 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1996-02-10 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1996-02-10 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1996-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1996-02-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1991)/1.73 sq M | 87 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1996-02-10 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1996-02-10 | Calcium [Mass/volume] in Serum or Plasma | 9.5 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1996-02-10 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 512 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1996-02-10 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1996-02-10 | Total score [MoCA] | 27 | {score} | S | ||
| 1996-02-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Carbidopa-levodopa 25/100 mg oral tablet, one tablet by mouth three times daily | One tablet by mouth three times daily, at about 7 a.m., noon, and 5 p.m. | Oral route | 1984-10-01 to 1996-03-10 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Parkinson's disease, young onset (diagnosed at 42), Hoehn and Yahr stage 2.5, without dyskinesia or motor fluctuations | active | confirmed | G20.A1 | S — Synthetic modern coding of the publicly disclosed diagnosis; the stage and the absence of motor complications are synthetic. |
| Hypokinetic dysarthria with soft speech due to Parkinson's disease | active | confirmed | R47.1 | S — Synthetic modern coding of the publicly reported speech difficulty; the severity is synthetic. |